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Functional magnetic resonance imaging (fMRI) based on the blood oxygenation 50 
level-dependent (BOLD) signal has been used to infer sites of neuronal activation in the 51 
brain. A recent study demonstrated, however, unexpected BOLD signal generation 52 
without neuronal excitation, which led us to hypothesize the presence of another cellular 53 
source for BOLD signal generation. Collective assessment of optogenetic activation of 54 
astrocytes or neurons, fMRI in awake mice, electrophysiological measurements, and 55 
histochemical detection of neuronal activation, coherently suggested astrocytes as 56 
another cellular source. Unexpectedly, astrocyte-evoked BOLD signal accompanied 57 
oxygen consumption without modulation of neuronal activity. Imaging mass 58 
spectrometry of brain sections identified synthesis of acetyl-carnitine via oxidative 59 
glucose metabolism at the site of astrocyte-, but not neuron-evoked BOLD signal. Our 60 
data provide causal evidence that astrocytic activation alone is able to evoke BOLD 61 
signal response, which may lead to reconsideration of current interpretation of BOLD 62 
signal as a marker of neuronal activation. 63 
 64 
Keywords 65 
astrocytes; BOLD; optogenetics; fMRI; imaging mass spectrometry   66 
Page 5 of 65





Blood oxygenation level-dependent (BOLD) functional magnetic resonance 68 
imaging (fMRI) is a fundamental imaging tool in basic and clinical investigations of 69 
human brain activity (Ogawa, Lee, Kay, & Tank, 1990). The BOLD signal is not a 70 
direct measurement of neuronal activity; instead, the signal is influenced by cerebral 71 
blood flow (CBF), cerebral blood volume (CBV), and the cerebral metabolic rate of 72 
oxygen consumption (Ogawa, Menon, Kim, & Ugurbil, 1998; Shen, Ren, & 73 
Duong, 2008). Despite the above caveats, the BOLD signal has been widely used as a 74 
surrogate marker of neuronal activation, because accumulating evidence has 75 
demonstrated a close correlation between BOLD signal response and 76 
electrophysiological activation of neurons following sensory stimulation (Logothetis, 77 
Pauls, Augath, Trinath, & Oeltermann, 2001; Niessing et al., 2005). Recent 78 
optogenetic fMRI (ofMRI) studies have further confirmed the correlation (Kahn et al., 79 
2013; Lee et al., 2010; Takata et al., 2015). However, the cellular mechanisms of 80 
BOLD signal generation have not been fully elucidated (Ekstrom, 2010; Vanzetta & 81 
Slovin, 2010). It is reported that coupling between BOLD and electrophysiological 82 
signal in visual cortex of behaving monkeys is context dependent (Maier et al., 2008). 83 
Furthermore, unexpected BOLD signal generation is found without activation of local 84 
neurons in the visual cortex of monkeys performing a fixation-on-off task (Sirotin & 85 
Das, 2009). 86 
Astrocytes are also considered to participate in BOLD signal generation 87 
(Haydon & Carmignoto, 2006; Otsu et al., 2015; Schummers, Yu, & Sur, 2008; Takano et 88 
al., 2006), but in a passive way that just couples neuronal activity to the hemodynamic 89 
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response to fulfill metabolic demand of neurons (Petzold & Murthy, 2011; Raichle & 90 
Mintun, 2006). A study that combined BOLD fMRI and fiber-optic calcium (Ca2+) 91 
recording in the cortex of anesthetized rats during electrical paw stimulation reported a 92 
correlation between prolonged BOLD signal components and Ca
2+
 surge in astrocytes, 93 
and their modeling suggested involvement of astrocytes in a late component of the BOLD 94 
response (Schulz et al., 2012). However, direct investigation of causal relationship 95 
between astrocyte activation and BOLD signal generation seems difficult to examine in 96 
the study, because sensory stimulation inevitably activates neurons in addition to 97 
astrocytes. Moreover, a recent study reported intact BOLD signal response upon hindpaw 98 
stimulation of anesthetized inositol 1,4,5-triphosphate receptor type 2 knock-out 99 
(IP3R2-KO) mice, which lack large cytosolic Ca
2+
 surges in astrocytes, suggesting a 100 
minor role of astrocytic Ca
2+
 activity in BOLD signal generation (Jego, 101 
Pacheco-Torres, Araque, & Canals, 2014) (but see (Srinivasan et al., 2015; Stobart 102 
et al., 2016) that demonstrate preserved Ca
2+
 dynamics in astrocytes of IP3R2-KO mice, 103 
and (Mishra et al., 2016) that shows multiple sources of calcium signals in astrocytes). 104 
Note that most of these studies were performed under anesthesia, which could affect 105 
neurovascular coupling, energy metabolism, and BOLD signal generation (Masamoto & 106 
Kanno, 2012; Sokoloff et al., 1977). 107 
This study aimed to investigate a causal relationship between astrocyte activity 108 
and BOLD signal generation using ofMRI in awake transgenic mice, whose cortical 109 
neurons or astrocytes express channelrhodopsin-2 (ChR2) (Tanaka et al., 2012). 110 
Optical activation of either neurons or astrocytes by light illumination through intact skull 111 
evoked a BOLD signal response in the cortex. Oxygen consumption upon stimulation of 112 
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either neurons or astrocytes was suggested by experiments of ofMRI in the presence of a 113 
vasodilator. Unexpectedly, optical activation of astrocytes did not modulate neuronal 114 
activity, which was confirmed with in situ hybridization for c-fos mRNA and in vivo 115 
electrophysiology. Metabolic underpinnings of the oxygen consumption was investigated 116 
with metabolite imaging of brain sections using imaging mass spectrometry (IMS). 117 
Activation of astrocytes, but not neurons, augmented synthesis of acetyl-carnitine (AC) 118 
from glucose, which consumed oxygen. Collectively, our findings demonstrate 119 
unexpected active role of astrocytes in BOLD signal generation. 120 
 121 
Materials and Methods 122 
fMRI in awake mice.  123 
We have elaborated fMRI in awake mice using a high signal-to-noise ratio 124 
cryogenic MRI detector, CryoProbe (Yoshida et al., 2016). Confounding effects of 125 
anesthetics during fMRI in awake mice were avoided because anesthesia is not necessary 126 
with this protocol to place awake mice in an animal bed of MRI. 127 
In vivo multichannel extracellular recordings.  128 
Extracellular recording was performed as described previously (Takata et al., 129 
2015). A 16-channel, linear silicon probe was inserted through a craniotomy (Φ 0.5 mm; 130 
AP -3.0 mm, ML -2.0 mm) for recording from the cortex, which corresponds to the site of 131 
global peak of BOLD signal response upon optogenetic astrocyte activation (Fig. 2c). 132 
IMS with FMW-assisted brain fixation for 
13
C6-glucose 133 
metabolic pathway tracing.  134 
Two-dimensional imaging of metabolites in the brain slices by combining IMS, 135 
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C-isotope was reported previously (Sugiura, Honda, Kajimura, & 136 
Suematsu, 2014; Sugiura, Taguchi, & Setou, 2011). To trace the metabolic fate of 137 
glucose, 
13
C6-glucose was injected intraperitoneally. Fifteen minutes later (Sugiura et 138 
al., 2014), optogenetic stimulation of the left cortex through the intact skull was 139 
performed. Thirty seconds later, mice were euthanized by FMW-irradiation for 0.96 s on 140 
the brain (Sugiura, Honda, & Suematsu, 2015). Matrix-assisted laser desorption 141 
ionization (MALDI)-IMS was performed on thin sections of the brain. See 142 
Supplementary Materials and Methods for more details. 143 
 144 
Results 145 
Transcranial illumination of the cortex of awake mice 146 
that express ChR2(C128S) in neurons or astrocytes. 147 
Double transgenic animals that express ChR2(C128S), a step-function 148 
opsin-type variant of ChR2 (Berndt, Yizhar, Gunaydin, Hegemann, & Deisseroth, 149 
2009), were generated by crossing a tetO-ChR2(C128S)-YFP line with a cell-type 150 
specific-tTA line (Tanaka et al., 2012); hereafter, we refer to 151 
Chrm4-tTA::tetO-ChR2(C128S)-YFP and Mlc1-tTA::tetO-ChR2(C128S)-YFP double 152 
transgenic lines as Neuron-ChR2 and Astrocyte-ChR2, respectively. For gene 153 
manipulation strategies to generate transgenic mice, see Supplementary Fig. 1. 154 
Expression of ChR2(C128S)-EYFP was observed in the cortex and sub-cortical brain 155 
structures of both Neuron- and Astrocyte-ChR2 mice (Fig. 1a, d). Double 156 
immunostaining for NeuN (neuron marker) and YFP (ChR2-marker) showed high 157 
expression levels of ChR2(C128S) at neuronal somas in layer IV and at dendrites in layer 158 
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II/III of the cortex of Neuron-ChR2 mice (Fig. 1b, c). In Astrocyte-ChR2 mice, almost 159 
uniform expression of ChR2(C128S) was observed throughout the cortical layers (Fig. 160 
1e). The enlarged view of the staining reveals the expression pattern of ChR2(C128S) 161 
with fine laminar morphology that is characteristic of astrocytes (Fig. 1f). Moreover, we 162 
have shown co-expression of ChR2(C128S) and GLAST, an astrocyte specific glutamate 163 
transporter, in the brain of Astrocyte-ChR2 mice (Tanaka et al., 2012), further 164 
confirming astrocytic expression of ChR2(C128S). Expression of ChR2(C128S) across a 165 
wide cortical area in these transgenic mice lines allows transcranial manipulation of 166 
neuronal or astrocytic activity because ChR2(C128S) has higher sensitivity than 167 
conventional ChR2 (Mattis et al., 2012). 168 
To perform light illumination through the intact skull of awake mice during 169 
fMRI experiments, a skull-holder and an optic fiber were attached horizontally on the 170 
skull (Yoshida et al., 2016). fMRI on awake mice is advantageous to avoid the 171 
confounding effects of anesthetics on neuronal and astrocytic activity (Greenberg, 172 
Houweling, & Kerr, 2008; Thrane et al., 2012). The tip of an optic fiber was 173 
positioned on the intact skull over the left visual cortex (Fig. 1g, h, i). 174 
Optogenetic stimulation of astrocytes as well as 175 
neurons evokes BOLD signal response.  176 
We investigated whether transcranial photo-activation of neurons or astrocytes 177 
was able to induce a BOLD signal response using Neuron- or Astrocyte-ChR2 mice, 178 
respectively. Transcranial manipulation is desirable to avoid inserting an optic fiber into 179 
the brain, which may result in “reactive astrocytes” with distinct physiological 180 
characteristics (Aguado, Espinosa-Parrilla, Carmona, & Soriano, 2002). We 181 
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applied a pair of blue and yellow lights with 30 s separation, which kept a cation channel 182 
of ChR2(C128S) open for 30 s. This pair of lights was repeated 3 times at an interval of 2 183 
min. The duration of each light was 0.5 and 5.0 s for Neuron- and Astrocyte-ChR2 mice, 184 
respectively. We employed longer illumination in Astrocyte-ChR2 mice because we 185 
speculated that effect of optogenetic stimulation was smaller in astrocytes, considering 186 
that astrocytic membrane resistance is lower than neurons. 187 
We found that transcranial optogenetic stimulation of either neurons or 188 
astrocytes could evoke a BOLD signal response in the cortex (Fig. 2a, c). The response 189 
was observed dominantly in the left cortex, which was ipsilateral to the site of light 190 
illumination. The most significant BOLD signal response was evoked within the cortex of 191 
Neuron- and Astrocyte-ChR2 mice (arrows in Fig. 2a, c). Subcortical BOLD signal 192 
response may reflect direct photo-activation, based on our measurements of ofMRI using 193 
a triple transgenic mouse whose astrocytes express ChR2(C128S) except in the cortex 194 
(see Supplementary Results and Supplementary Fig. 2a-d). In addition, light illumination 195 
for optogenetic stimulation seemed not enough to evoke BOLD signal response through 196 
visual stimulation nor brain-tissue heating (see Supplementary Results and 197 
Supplementary Fig. 3a, b). Further, open field test and ofMRI using anesthetized 198 
Astrocyte-ChR2 mice suggested that behavioral state-change, which may cause 199 
widespread astrocyte excitation in the brain, seemed not to contaminate BOLD signal 200 
fluctuation upon optogenetic stimulation of astrocytes (see Supplementary Results, 201 
Supplementary Fig. 2e, f, and Supplementary Fig. 4). 202 
We compared temporal dynamics of BOLD signal fluctuations at the site of the 203 
most significant response upon optogenetic stimulation of Neuron- or Astrocyte-ChR2 204 
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mice, respectively (arrows in Fig. 2a, c). A BOLD signal response could be evoked 205 
repeatedly in both Neuron- and Astrocyte-ChR2 mice (Fig. 2b, d). Peak amplitudes of the 206 
response during the first stimulation period, i.e., 30 s-period between a pair of blue and 207 
yellow vertical lines (Fig. 2b, d), were significantly higher for Neuron- than 208 
Astrocyte-ChR2 mice (6.1 ± 0.4% versus 4.7 ± 0.5%, P = 0.03, n = 12 and 9 animals for 209 
Neuron- and Astrocyte-ChR2 mice, respectively; two-sample t-test). The magnitude of 210 
the BOLD signal response was dependent on the light intensities (Supplementary Fig. 3c, 211 
d). 212 
Oxygen consumption is elicited by optogenetic 213 
stimulation of either astrocytes or neurons.  214 
Because BOLD signal has been considered to reflect augmentation of the 215 
metabolic demand of neurons (Heeger & Ress, 2002), we addressed whether 216 
astrocyte-evoked BOLD signal response resulted in oxygen consumption. We performed 217 
ofMRI after injection of a nitric oxide-releasing vasodilator, sodium nitroprusside (SNP), 218 
so that oxygen consumption could be detected as negative deflection of the BOLD signal 219 
(Nagaoka et al., 2006). 220 
Neuronal activation by optogenetic stimulation using Neuron-ChR2 mice in the 221 
presence of SNP resulted in a negative BOLD response (Fig. 2e, f), which was in good 222 
accordance with previous studies (Nagaoka et al., 2006; Tsurugizawa, Ciobanu, & 223 
Le Bihan, 2013). The location of the most significant negative BOLD signal was 224 
similar to that of the positive BOLD response in ofMRI experiments without SNP 225 
(compare arrows in Fig. 2a and e). The negative deflection of the BOLD signal occurred 226 
only once, followed by a gradual increase that exceeded baseline (Fig. 2f) (see below). 227 
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Astrocyte activation by optogenetic stimulation using Astrocyte-ChR2 mice in 228 
the presence of SNP also resulted in a negative BOLD response (Fig. 2g, h), which 229 
suggests that activation of astrocytes results in oxygen consumption. The location of the 230 
most significant negative BOLD signal was comparable to that of the positive BOLD 231 
response in ofMRI experiments without SNP (compare arrows in Fig. 2c and g). Negative 232 
deflection of the BOLD response was observed only once to the first optogenetic 233 
stimulation of astrocytes (Fig. 2h), which was similar to the result in Neuron-ChR2 mice 234 
(Fig. 2f), although the gradual increase of the BOLD signal after the first optogenetic 235 
stimulation was not as clear as that in Neuron-ChR2 mice. 236 
It’s not clear in this study why negative deflection was hardly induced by the 237 
second and the third illumination on Neuron- or Astrocyte-ChR2 mice. BOLD signal is 238 
assumed to reflect increase of 1) blood volume, 2) blood flow, and 3) oxygenation in the 239 
blood (Shen et al., 2008). Considering that SNP suppresses the first two factors, gradual 240 
increase of BOLD signals might indicate physiological response to suppress oxygen 241 
consumption in the brain in the presence of SNP after the first optical stimulation. This 242 
might explain the absence of negative BOLD response upon the second and the third 243 
illumination. 244 
Neuronal activation is not observed by optogenetic 245 
stimulation of astrocytes.  246 
Because BOLD signal is used as a marker of neuronal activation, we examined 247 
the modulation of neuronal activity upon optogenetic stimulation of Neuron- or 248 
Astrocyte-ChR2 mice. We first performed in situ hybridization for c-fos mRNA, a 249 
neuronal activity marker, to obtain the spatial distribution of neuronal activation. Animals 250 
were perfused 30 min after optogenetic stimulation, and then post-fixed, sliced, and 251 
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stained for c-fos mRNA. 252 
Neuronal activation of Neuron-ChR2 mice increased c-fos mRNA staining in the 253 
ipsilateral cortex to the site of light illumination (Fig. 3a), which is consistent with 254 
previous reports (Stark, Davies, Williams, & Luckman, 2006). Unexpectedly, 255 
astrocyte activation of Astrocyte-ChR2 mice did not augment c-fos mRNA staining (Fig. 256 
3b). We quantified staining intensity for c-fos mRNA in the left and right cortex (blue and 257 
red rectangles in Fig. 3a, b, respectively) by calculating their mean pixel values. While 258 
Neuron-ChR2 mice showed significantly higher staining for c-fos mRNA in the left 259 
cortex than that in the right cortex (107 ± 3 versus 83 ± 7 in the left and right cortex, P = 260 
0.02, n = 9 mice, paired t-test; Fig. 3a), Astrocyte-ChR2 mice showed comparable 261 
staining for c-fos mRNA in the left and right cortex (79 ± 6 versus 79 ± 6 in the left and 262 
right cortex, P = 0.86, n = 9 mice, paired t-test; Fig. 3b). 263 
This result cannot distinguish the following possibilities: 1) optogenetic 264 
activation of astrocytes indeed did not modulate neuronal activity, or 2) it did modulate 265 
neuronal activity, but was not enough to increase expression of c-fos mRNA. To directly 266 
examine neuronal activity upon optogenetic stimulation of neurons or astrocytes, we next 267 
performed electrophysiological recording in the cortex of awake, head-fixed Neuron- or 268 
Astrocyte-ChR2 mice, using a linear 16-channel silicon probe electrode. This was a 269 
separate experiment to the ofMRI. Again, we observed neuronal activation upon 270 
optogenetic stimulation of Neuron-, but not of Astrocyte-ChR2 mice (Fig. 3c-f), 271 
supporting the first possibility. 272 
Specifically, in Neuron-ChR2 mice, local field potential (LFP) power at the 273 
gamma and high frequency oscillation (HFO) significantly increased at the beginning of 274 
Page 14 of 65




the stimulation, followed by a gradual decrease (Fig. 3c). Average power of LFP at 275 
gamma and HFO during the period of the first light-activation was significantly higher 276 
than that during the pre-stimulus period (bar graph at lower right of Fig. 3c; 6.3 ± 1.2 and 277 
2.0 ± 0.6 for gamma and HFP; P = 0.003 and 0.02, respectively; n = 6 mice, paired t-test). 278 
Multi-unit activities (MUA) in the cortex were also augmented by the optogenetic 279 
stimulation of Neuron-ChR2 mice (Fig. 3e). The mean relative number of spikes during 280 
the first activation period (60~90 s) was significantly higher than that during the 281 
pre-stimulus period (lower panel of Fig. 3e; 3.4 ± 0.6, P = 0.01, n = 6 mice, paired t-test). 282 
These results are in good accordance with previous reports (Kahn et al., 2013; Lee et 283 
al., 2010; Takata et al., 2015). 284 
In Astrocyte-ChR2 mice, optogenetic activation of astrocytes did not modulate 285 
LFP power (Fig. 3d). The average power of LFP during the first light activation period 286 
was not different from that during the pre-stimulus period (bar graph at lower right of Fig. 287 
3d; -0.2 ± 0.3, -0.5 ± 0.4, -0.4 ± 0.4, and -0.1 ± 0.3 for delta, theta, gamma, and HFO, 288 
respectively, P > 0.25, n = 5 mice, paired t-test). Neither was MUA modulated (mean 289 
relative number of spikes during the first activation period: 1.3 ± 0.2, P = 0.22, n = 5 mice, 290 
paired t-test). 291 
Illumination using only yellow light did not evoke electrophysiological response 292 
in Neuron- or Astrocyte-ChR2 mice (Supplementary Fig. 5a–d). The magnitude of 293 
electrophysiological response was dependent on intensities of blue light (Supplementary 294 
Fig. 5e–h). These results were consistent with that of ofMRI (Supplementary Fig. 3). 295 
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C6-glucose is metabolized into 
13
C2-AC by optogenetic 296 
activation of astrocytes, but not neurons. 297 
We asked whether neuron- or astrocyte-evoked BOLD signal was underlain by 298 
the same metabolic activity because astrocyte-evoked BOLD signal accompanied oxygen 299 
consumption without neuronal activation (Fig. 2 and 3). We used IMS to examine 300 
two-dimensional distribution of brain metabolites upon optogenetic stimulation of 301 
Neuron- or Astrocyte-ChR2 mice (n = 3 and 5 mice, respectively). Intraperitoneal 302 
injection of 
13
C-isotope labeled glucose (
13
C6-glucose) was performed fifteen minutes 303 
before optogenetic stimulation, which allowed us to trace flows of 
13
C from glucose to 304 
various metabolites (Fig. 4a, b). Transcranial light illumination for optogenetic 305 
stimulation of neurons or astrocytes was executed as before. Thirty seconds after the 306 
stimulation, focused microwave (FMW) irradiation was applied for 0.92 s to the head of 307 
the mouse to rapidly inactivate enzymatic reactions in the brain, which minimizes 308 
postmortem alterations in metabolites during brain extraction (Sugiura et al., 2015). 309 
Brains were then extracted, frozen, and sliced coronally at a thickness of 8 µm. The 310 
spatial distribution of 
13
C-containing metabolites that were synthesized from 311 
13
C6-glucose was explored and visualized using IMS. 312 
Optogenetic stimulation of astrocytes, but not neurons, resulted in an increase of 313 
non-labeled AC and 
13
C2-AC at the site of light illumination in the cortex (Fig. 4c and d, 314 
middle row), suggesting that AC was metabolized from glucose via oxidative 315 
decarboxylation of pyruvate to produce acetyl-CoA followed by transfer of acetyl-group 316 
to carnitine (Fig. 4b). Concomitantly, reduction of carnitine, a substrate for AC synthesis, 317 
was observed at the same region in the brain of Astrocyte-ChR2 mice (dotted circles in 318 
Fig. 4d, upper right panel), indicating that synthesis of AC from acetyl-CoA and carnitine 319 
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occurred in the brain. Spatial patterns of fluctuation of these metabolites were similar to 320 
that of the BOLD signal response upon astrocyte activation (compare Fig. 2c with the 321 
bottom panels of Fig. 4d or Supplementary Fig. 6a), implying that astrocyte activation 322 
accelerated the metabolic pathway that produces AC in the brain. Notably, optogenetic 323 
stimulation of astrocytes did not result in accumulation of NADH (Supplementary Fig. 6b, 324 
upper right panel). This suggests the presence of oxidative conversion of NADH to NAD
+
 325 
by mitochondrial complex I activity (Fig. 4b). These imaging results were also supported 326 
by a capillary electrophoresis (CE)-electrospray ionization (ESI)-mass spectrometry 327 
(MS) technique (Morikawa et al., 2012; Sugiura et al., 2016) (Supplementary Fig. 328 
7). Taken together, these results suggest that while comparable a BOLD signal response 329 
was evoked by optogenetic stimulation of either neurons or astrocytes, the respective 330 
BOLD signal fluctuations were accompanied by distinct metabolic flows. 331 
 332 
Discussion 333 
We demonstrated that 1) selective stimulation of astrocytes is sufficient for the 334 
induction of a BOLD signal response with oxygen consumption in the absence of 335 
neuronal activation, and 2) activation of astrocytes, but not neurons, resulted in glucose 336 
oxidation with production of AC, which is known to modulate neuronal energy processes 337 
(Pettegrew, Levine, & McClure, 2000; Traina, 2016). Our data present a causal 338 
relationship between astrocyte activation and BOLD signal generation, suggesting that 339 
BOLD signal fluctuations can reflect metabolic demands of astrocytes in addition to 340 
neurons. These findings may challenge the current interpretation of the BOLD signal 341 
response as a surrogate marker of neuronal activation in fMRI studies (Figley & 342 
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Stroman, 2011; Gurden, 2013). 343 
The physiological relevance of optogenetic stimulation of astrocytes has not 344 
been resolved completely, while increasingly many studies have recently employed 345 
optogenetic manipulation of astrocytes to utilize its advantages to shift the states of 346 
astrocytes non-invasively with cell-type specificity (Figueiredo et al., 2014; Gourine 347 
et al., 2010; Masamoto et al., 2015; Pelluru, Konadhode, Bhat, & Shiromani, 348 
2016; Perea, Yang, Boyden, & Sur, 2014; Sasaki et al., 2012; Tanaka et al., 349 
2012; Tang et al., 2014). The responses of astrocytes upon optogenetic activation have 350 
been reported as a few mV of depolarization, pH decrease, and cytosolic Ca
2+
 surge 351 
(Beppu et al., 2014; Perea et al., 2014; Sasaki et al., 2012), which can be 352 
observed in physiological situations (MacVicar, Crichton, Burnard, & Tse, 1987; Rose & 353 
Ransom, 1996; Seigneur, Kroeger, Nita, & Amzica, 2006; Takata et al., 2011). 354 
Among the above three responses, depolarization of astrocytes might be the 355 
primary cause for BOLD signal induction in the current study, because we reported 356 
previously that astrocytic depolarization was coupled to efflux of potassium ions, a potent 357 
vasodilator, from astrocytes (Masamoto et al., 2015; Sasaki et al., 2012). Although we 358 
have shown that only ~5 mV depolarization was evoked with significantly larger light 359 
power (7 mW/mm
2
 blue light illumination for 10 s; see Supplementary Materials and 360 
Methods) on Bergmann glial cells (astrocytes in the cerebellum) in slice preparation from 361 
young Astrocyte-ChR2 mice (postnatal day 17 to 24), we have also demonstrated that 362 
amplitude of optogenetically induced inward currents developed age-dependent manner 363 
(Sasaki et al., 2012), suggesting that effect of optogenetic stimulation is larger in the 364 
current study that uses adult Astrocyte-ChR2 mice. 365 
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In the current study, optogenetic stimulation of astrocytes did not significantly 366 
activate neurons, which may appear inconsistent with previous reports that showed 367 
induction of c-fos mRNA in neuronal and/or glial cells upon optogenetic activation of 368 
astrocytes in the cortex or cerebellum using Astrocyte-ChR2 mice (Sasaki et al., 2012; 369 
Tanaka et al., 2012). While light intensity at the tip of the optic fiber was comparable 370 
among studies, the layout of the optic fiber differed: earlier studies placed an optic fiber 371 
perpendicular to the cranial skull, while the fiber was placed horizontally in the present 372 
study. Thus, it is conceivable that less light reached the brain in the current study, which 373 
may explain the lack of modulation of neuronal activity upon optogenetic manipulation 374 
of astrocytes. In line with this, astrocytes show distinct physiological response depending 375 
on stimulation intensity (Sekiguchi et al., 2016). It is possible that previous studies 376 
employed light illumination that was strong enough to modulate neuronal activity, 377 
because most of the studies used neuronal response as a readout for optogenetic 378 
manipulation of astrocytes. It should be noted, however, that axonal activity cannot be 379 
detected with our extracellular electrodes. Therefore, the current study cannot exclude a 380 
possibility that optogenetic manipulation of astrocytes might have modulated axonal 381 
activity (Tang et al., 2014), which may lead to BOLD signal generation. Note that even 382 
in this case, our results support the idea of causal involvement of astrocytes in BOLD 383 
signal generation. 384 
Optogenetic stimulation of astrocytes resulted in unexpected oxygen 385 
consumption without neuronal activation. We have previously shown that optogenetic 386 
activation of astrocytes results in potassium efflux from astrocytes (Masamoto et al., 387 
2015), which should be followed by restoration of the ionic gradient of astrocytes by 388 
Page 19 of 65








-ATPase. Thus, synthesis of adenosine triphosphate (ATP) might be a candidate 389 
to account for the oxygen consumption, although we did not observe a significant 390 
increase in ATP upon optogenetic stimulation of astrocytes (Supplementary Fig. 6). AC 391 
might be another candidate for oxygen consumption upon optogenetic astrocyte 392 
activation, because metabolism from glucose to AC involves production of NADH, an 393 
electron donor that transfers an electron to molecular oxygen during oxidative 394 
phosphorylation in mitochondria (Fig. 4b). In accord with this idea, NADH was not 395 
accumulated (Supplementary Fig. 6) while AC synthesis was evident (Fig. 4d) upon 396 
optogenetic stimulation of astrocytes, suggesting consumption of a molecular oxygen by 397 
oxidization of NADH to NAD
+
 in mitochondria (Fig. 4b). See Supplementary Discussion 398 
on the possibility of AC as an energy substrate for neurons. 399 
 The BOLD signal response has been used to infer activation of neurons because 400 
accumulating evidence has shown a close correlation between BOLD signal fluctuations 401 
and electrophysiological activation of neurons (Logothetis et al., 2001; Niessing et 402 
al., 2005). However, in the present study, we demonstrated that astrocytes can evoke a 403 
BOLD signal response that accompanies oxygen consumption without activation of local 404 
neurons. This may suggest the existence of BOLD signal fluctuations that are irrelevant 405 
to activation of local neurons. Indeed, a recent study found unexpected BOLD signal 406 
fluctuations that occurred without activation of local neurons during a repeated 407 
anticipation task (Sirotin & Das, 2009). Activation of astrocytes might be a cellular 408 
substrate underlying this type of BOLD signal fluctuation. What physiological 409 
mechanism might stimulate astrocytes without activation of local neurons? One 410 
possibility might be the release of neuromodulator(s) from axonal fibers of distant origin. 411 
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It’s shown that astrocytes are sensitive to neuromodulators such as acetylcholine and 412 
noradrenalin, which can be released in the cortex by axonal fibers ascending from the 413 
Meynert nucleus or Locus coeruleus, respectively (Bekar, He, & Nedergaard, 2008; 414 
Pankratov & Lalo, 2015; Takata et al., 2011). Thus, astrocytes may be able to 415 
respond to neuromodulatory activity of remote neurons, by augmenting metabolic 416 
activity including synthesis of AC that can be used as preparatory energy fuel for local 417 
neurons.   418 
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Figure Legends 622 
Figure 1. Transgenic mice that express 623 
ChR2(C128S)-EYFP at neurons or astrocytes. 624 
(a, d) Immunostaining against YFP (ChR2-marker) on coronal sections of the brain from 625 
Neuron- (a) and Astrocyte-ChR2 mice (d). (b, e) Double-immunostaining for NeuN 626 
(neuron marker, red) and YFP (green) of coronal sections of the brain from Neuron- (b) 627 
and Astrocyte-ChR2 mice (e). (c, f) Higher magnification images of cortical layer IV of 628 
Neuron- or Astrocyte-ChR2 mice. (g) Schematic drawings of attachment of a headbar 629 
(gray) and an optic fiber with a cannula (red) on the intact skull. A headbar was used for 630 
cranial fixation during ofMRI in awake mice. (h) A photograph of a transgenic mouse 631 
with an attached headbar (arrow head) and a fiber optic cannula (arrow). (i) Estimated 632 
area of illumination (pale blue) by an optic fiber (red), drawn over a horizontal (left) and a 633 
sagittal (right) brain section of an anatomical MRI image. Scale bar: a,d, 3 mm; b,e, 200 634 
µm; c,f, 50 µm; g,h,i, 5 mm. 635 
Figure 2. Transcranial optogenetic stimulation of 636 
neurons or astrocytes evoked BOLD signal response 637 
with oxygen consumption. 638 
(a, c) Activation t-maps overlaid on structural MRI images showing spatial distribution 639 
of positive BOLD response upon optogenetic activation of cortical neurons (a) or 640 
astrocytes (c) from n = 13 Neuron- or 9 Astrocyte-ChR2 mice, respectively. Illumination 641 
was applied on the left side of the skull (left side in the figure). Values at the lower left 642 
indicate anterior-posterior (AP) distance from bregma in mm. Color bar indicates t-values. 643 
Arrows at AP -4.0 and -3.0 mm in (a) and (c), respectively, indicate approximate position 644 
of a global peak of t-values, which were used for locations of ROIs for BOLD time 645 
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courses. (b, d) Time-course of BOLD signal fluctuation upon optogenetic activation of 646 
neurons (b) or astrocytes (d). Blue and yellow vertical lines show timing of illumination 647 
for each color. Note that ChR2(C128S), a step function opsin with the closing time 648 
constant (τ) of 106 s, was kept open even after cessation of blue illumination until yellow 649 
illumination. The x-axis at the top shows the scan number of fMRI measurements. Gray 650 
shading indicates the SEM. (e–h) The same as (a–d), but in the presence of a vasodilator, 651 
SNP, from n = 3 Neuron- or 3 Astrocyte-ChR2 mice, respectively, showing negative 652 
BOLD response that indicates oxygen consumption upon optogenetic activation of 653 
neurons (f) or astrocytes (h). Scale bar: a, c, e, g, 2 mm. 654 
Figure 3. Optogenetic stimulation of neurons, but not 655 
astrocytes, results in neuronal activation. 656 
(a, b) Representative images of in situ hybridization on coronal brain sections around AP 657 
-2.0 mm for c-fos mRNA, 30 min after optogenetic stimulation of cortical neurons (a) or 658 
astrocytes (b) using Neuron- or Astrocyte-ChR2 mice, respectively (n = 9 each). 659 
Optogenetic stimulation of neurons, but not astrocytes, induced expression of c-fos 660 
mRNA (blue-purple signal) in the cortex ipsilateral to light illumination. Rectangles in 661 
blue and red were for quantification of staining intensity of c-fos mRNA. Scale bar: 1 mm. 662 
(c, d) LFP fluctuations upon optogenetic stimulation of Neuron- (c) or Astrocyte-ChR2 663 
mice (d). Upper left: Representative traces of LFP recorded with a silicon probe 664 
electrode, inserted into the cortex of an awake Neuron- (c) or Astrocyte-ChR2 mouse (d). 665 
The blue area indicates the period of blue-light illumination. Note that the duration of 666 
light illumination was 0.5 and 5.0 s for Neuron- and Astrocyte-ChR2 mice, respectively. 667 
Upper right: Mean wavelet power spectrogram of LFP recorded in the cortex of n = 6 668 
Neuron- (c) or n = 5 Astrocyte-ChR2 mice (d). Power values of LFP were normalized for 669 
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each recording session (see methods). Blue and yellow triangles with white vertical lines 670 
indicate the delivery of blue and yellow light pulses, respectively. Lower left: Mean time 671 
courses of LFP-power at each frequency band. Vertical lines of blue and yellow indicate 672 
the delivery of light pulses of each color. The SEM envelopes the mean traces. Lower 673 
right: The bar graph compares the mean power of LFP at each frequency band during the 674 
first activation period (60~90 s). No modulation of LFP power was observed in 675 
Astrocyte-ChR2 mice (d). *P < 0.05, **P < 0.01; paired t-test. (e, f) MUA response upon 676 
optogenetic stimulation of Neuron- (e) or Astrocyte-ChR2 mice (f). Upper left: A 677 
representative time course of high-pass filtered LFP (upper trace) and MUA (lower trace). 678 
A horizontal red line in the upper trace indicates a threshold for MUA extraction. Upper 679 
right: Representative mean traces of MUA during a baseline period (0~60 s, blue), and 1
st
 680 
(60~90 s, green), 2
nd
 (210~240 s, red), and 3
rd
 (360~390 s, pale blue) activation periods. 681 
Lower panel: Relative number of MUA counts, recorded from the most superficial 10 682 
channels of the silicon probe in the cortex, from n = 6 Neuron- (e) and n = 5 683 
Astrocyte-ChR2 mice (f). The SEM envelopes the mean traces. 684 
Figure 4. Synthesis of AC at the site of optogenetic 685 
activation of astrocytes, but not of neurons. 686 
(a) Upper panel: Schematic of IMS experiments, which involved pathway tracing of 687 
13
C6-labeled glucose upon optogenetic stimulation. A red circle indicates 
13
C-isotope in a 688 
glucose molecule. Optic fiber was attached on the left intact skull. Lower panel: 689 
Experimental time course. FMW fixation of the brain was performed 30 s following 690 
optogenetic stimulation. (b) Schematic representation of 
13
C6-glucose metabolism into 691 
acetyl-carnitine (AC). (c, d) Representative IMS images for carnitine (right top), AC (left 692 
middle), 
13
C2-AC (middle right), AC/carnitine ratio (left bottom), and 
13
C2-AC/carnitine 693 
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ratio (right bottom), after optogenetic stimulation of a Neuron- (c) or an Astrocyte-ChR2 694 
mouse (d). Astrocyte activation augmented synthesis of AC that accompanies O2 695 
consumption (d, left middle). Upper left panel shows optical images of brain sections 696 
used for IMS. Each panel shows three consecutive slices. Dotted circles in a top right 697 
panel in (d) indicates area that showed reduction of carnitine. These experiments were 698 
repeated with n = 3 Neuron- and n = 5 Astrocyte-ChR2 mice, obtaining similar results. 699 
Scale bar: c,d, 2 mm. 700 
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Figure 1. Transgenic mice that express ChR2(C128S)-EYFP at neurons or astrocytes.  
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Figure 2. Transcranial optogenetic stimulation of neurons or astrocytes evoked BOLD signal response with 
oxygen consumption.  
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Figure 3. Optogenetic stimulation of neurons, but not astrocytes, results in neuronal activation.  
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Figure 4. Synthesis of AC at the site of optogenetic activation of astrocytes, but not of neurons.  
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Running title: Astrocytes evoke BOLD fMRI response 1 
Supplementary Materials and Methods 2 
Ethics Statement 3 
All animal experiments were conducted in accordance with the National 4 
Institutes of Health Guide for Care and Use of Laboratory Animals (NIH Publications No. 5 
8023) and approved by the Animal Ethics Committee of Keio University (approval 6 
number: 12034-(3)) and CIEA (16062A). 7 
Generation of Chrm4-tTA BAC transgenic mice 8 
Mouse BAC DNA (clone RP23-138P5) was modified by inserting a codon 9 
optimized tTA (mtTA)-SV40 pA cassette (Tanaka et al., 2010) into the translation 10 
initiation site of Chrm4 gene. Modified BAC DNA was linearized by PI-SceI enzyme 11 
digestion (New England Biolabs Inc., Ipswich, MA, USA), and injected into fertilized 12 
eggs from CBA/C57BL6 mice. For genotyping of Chrm4-tTA line, the following primer 13 
set Chrm-394U (5’-AAGCACCAAGTTCTCTCCCGTCTT-3’) and mtTAL24 14 
(5’-cggagttgatcaccttggacttgt-3’) was used and the transgenic line yielded 430 bp product. 15 
Generation of ChR2(C128S) expressing lines 16 
Double transgenic mice of Chrm4-tTA::tetO-ChR2(C128S)-EYFP and 17 
Mlc1-tTA::tetO-ChR2(C128S)-EYFP were prepared for experiments. Mlc1-tTA BAC 18 
transgenic mouse (RIKEN BRC stock number:05450) and tetO-ChR2(C128S)-EYFP 19 
knockin mouse (RIKEN BRC stock number: 05454) were obtained from RIKEN 20 
BioResource Center, JAPAN, and the methods for genotyping were previously described 21 
(Kanemaru et al., 2014; Tanaka et al., 2012). 22 
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Surgery for attaching an optical fiber and a head-holder 23 
on the skull of the mice 24 
In total, 51 double transgenic mice, postnatal 8–12 weeks old, were used; 26 25 
were Chrm4-tTA::tetO-ChR2(C128S) mice (9 males and 17 females) and 25 were 26 
Mlc1-tTA::tetO-ChR2(C128S)-EYFP mice (13 males and 12 females). Animals were 27 
anesthetized with a mixture of ketamine and xylazine (100 mg/kg and 10 mg/kg, 28 
respectively, i.p.). After skull exposure, an optical fiber of silica glass (Φ 400 µm, 29 
CFML14L05, Thorlabs, NJ, USA) was placed on the surface of the skull horizontally to 30 
the bregma-lambda line. The side of an optical fiber was painted in black to avoid stray 31 
light. The tip of an optical fiber was located at -5.1 mm posterior to the Bregma (AP -5.1 32 
mm), 3.0 mm lateral from the midline to the left (ML -3.0 mm), and 0.6 mm ventral from 33 
the horizontal plane passing through bregma and lambda on the surface of the skull (DV 34 
+0.6 mm). The tip of an optical fiber was imbedded with a transparent silicone (Φ 200 µm, 35 
Kwik-Sil Adhesive, WPI, FL, USA). Optical fiber was then attached on the skull with 36 
dental acrylic (Super-Bond C&B, Sun Medical, Shiga, Japan). In the case of IMS 37 
experiments, an optical fiber of plastic (Φ 500 µm, Eska SK20, Mitsubishi Chemical, 38 
Tokyo, Japan) was used instead of an optical fiber of silica glass. 39 
Next, a custom-made acrylic head bar (3 × 3 × 27 mm3) was mounted along the 40 
sagittal suture of the exposed skull using the dental cement for fMRI in awake mice 41 
(Yoshida et al., 2016). For experiments of in vivo electrophysiology, a custom-made 42 
U-shaped plastic plate was attached on the skull instead of a head bar to enable fixation of 43 
the mouse’s head to a stereotaxic frame (SR-6M-HT, Narishige, Tokyo, Japan) during 44 
recording. For IMS experiments, a head-holder was not attached because a head of a 45 
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mouse is fixed in a dedicated tube (WJM-24 or WJM-28, Muromachi Kikai, Tokyo, 46 
Japan). After covering the exposed skull with the dental acrylic, the animal was returned 47 
to its homecage for recovery (Yoshida et al., 2016). 48 
fMRI in awake mice 49 
Mice were acclimated to mock fMRI environment for 2 hrs/day for at least 7 50 
days before performing fMRI in awake mice (Yoshida et al., 2016). Structural and 51 
functional MRI was performed as described previously (Komaki et al., 2016; Takata 52 
et al., 2015) using a 7.0-Tesla MRI apparatus equipped with actively shielded gradients 53 
at a maximum strength of 700 mT/m (Biospec 70/16, Bruker BioSpin AG, Fällanden, 54 
Switzerland) with a cryogenically cooled 2-ch transmit/receive phased array surface coil 55 
(CryoProbe, Z120046, Bruker BioSpin AG, Fällanden, Switzerland), and the ParaVision 56 
5.1 software interface (Bruker Biospin AG, Fällanden, Switzerland). Structural 57 
T2-weighted images were acquired using a rapid acquisition process with a relaxation 58 
enhancement (RARE) sequence in coronal orientations (repetition time [TR], 6100 ms; 59 
echo time [TE], 48 ms; spectral bandwidth [BW], 5 kHz; RARE factor, 8; number of 60 
averages, 4; number of slices 52; spatial resolution, 75 × 75 × 300 µm
3
). Before fMRI 61 
measurement, a field map was acquired to reduce signal loss artifacts (TE, 1.520 ms; 62 
5.325 ms; TR, 20 ms; spatial resolution, 300 × 300 × 300 µm
3
; matrix, 64 × 64 × 64 63 
voxels). fMRI was performed using a gradient-echo echo-planar sequence (TR, 1500 ms; 64 
TE, 20 ms; BW, 250 kHz; flip angle, 50°; number of segments, 1; number of averages 1; 65 
number of slices 18; spatial resolution, 200 × 200 × 500 µm
3
; FOV, 19.2 × 19.2 mm
2
; 66 
matrix, 96 × 96 × 18 voxels). This functional image covered the whole brain except the 67 
olfactory bulb and the cerebellum. Total scanning time was 8.5 min (340 volumes with a 68 
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1.5-s interval). In ofMRI experiments in the presence of a nitric oxide donor, 69 
subcutaneous injection of S-nitroprusside (SNP, 10 mg/kg, Sigma-Aldrich, MO, USA) 70 
was performed five minutes before the start of fMRI measurements (Nagaoka et al., 71 
2006; Tsurugizawa, Ciobanu, & Le Bihan, 2013; Yamamoto, 1992). 72 
Transcranial light illumination 73 
A pair of blue and yellow light pulses with 30-s intervals (1.1~2.5 mW at the tip 74 
of an optical fiber; LEDC2-B/A, Doric Lenses, QC, Canada) were delivered 60-s after the 75 
start of fMRI measurements. Pulse duration was 0.5 s and 5 s for experiments with 76 
Neuron- and Astrocyte-ChR2 mice, respectively. In the case of IMS experiments, only 77 
the first blue light was delivered, 30–40 s after which FMW was applied to inactivate 78 
enzymatic reactions in the brain. Area of illumination was estimated to cover the left 79 
parietal cortex based on calculation using numerical aperture and diameter of the optic 80 
fiber without considering light scattering in the skull and the cerebral parenchyma (Fig. 81 
1i). Power of illuminated light beneath the skull was estimated to be ~5% of that at the tip 82 
of an optical fiber, based on our measurement using a power meter (PM160T, Thorlabs, 83 
NJ, USA; detector ø10 mm) that was put beneath the skull (0.15 and 2.7 mW, 84 
respectively). Estimated irradiance beneath the skull is ~0.002 mW/mm
2
, which 85 
corresponds to half-maximal activation (EPD50) of ChR2(C128S) (Mattis et al., 2012). 86 
In vivo multichannel extracellular recordings 87 
Extracellular recording was made from awake transgenic mice using a 88 
16-channel, linear silicon probe (100-µm spacing, 177-µm
2
 recording site area; 89 
NeuroNexus, MI, USA), which was inserted through a craniotomy (Φ 0.5 mm; AP -3.0 90 
mm, ML -2.0 mm) at a depth of 1.7 mm ventrally from the pia for recording from the 91 
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cortex. The craniotomy was sealed with a mixture of wax and paraffin oil. Recording 92 
sessions started > 1 h after insertion of the silicon probe for recovery (Takata et al., 93 
2014). Electrophysiological signals were recorded with a RZ2 neurophysiology 94 
workstation (Tucker-Davis Technologies, FL, USA). 95 
IMS with FMW-assisted brain fixation for 
13
C6-glucose 96 
metabolic pathway tracing 97 
 To trace the metabolic fate of glucose, 
13
C6-glucose (1 mg/g body weight, in 98 
saline) was injected intraperitoneally. Fifteen minutes later (Sugiura, Honda, 99 
Kajimura, & Suematsu, 2014), optogenetic stimulation of neurons or astrocytes was 100 
performed with illumination of blue light for 0.5 or 5 s transcranially on the left 101 
hemisphere of the brain of Neuron- or Astrocyte-ChR2 mice, respectively. Mice were 102 
then confined in a tubulous, water-jacket holder (WJM-24 or 28, Muromachi Kikai, 103 
Tokyo, Japan), and placed inside a microwave fixation system (MMW-05, Muromachi 104 
Kikai, Tokyo, Japan). Thirty seconds after the optogenetic stimulation, mice were 105 
euthanized by FMW-irradiation on the brain (5 kW for 0.96 s), which immediately 106 
elevated the temperature of the brain up to 80°C to inactivate metabolic enzymes and 107 
minimize postmortem changes in labile metabolites (Sugiura, Honda, & Suematsu, 108 
2015). After microwave irradiation, brains were dissected with a surgical knife at room 109 
temperature, embedded into a super cryo-embedding medium (SCEM, Section Lab, 110 
Hiroshima, Japan), rapidly frozen in liquid N2, and stored at -80°C.  111 
Thin sections of the frozen brain were prepared with a cryomicrotome (CM3050, 112 
Leica Microsystems, Wetzlar, Germany) and thaw-mounted on an indium thin 113 
oxide-coated glass slide (Bruker Daltonics, Leipzig, Germany) at -16°C. Slices were then 114 
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manually spray-coated with 9-aminoacridine (10 mg/mL, dissolved in 80% ethanol) and 115 
2,5-dihydroxybenzoic acid (DHB) as a matrix (50 mg/mL, dissolved in 80% ethanol) for 116 
anion and cation metabolites, respectively. Matrix-assisted laser desorption ionization 117 
(MALDI)-IMS was performed using an Ultra Flextreme MALDI-TOF mass 118 
spectrometer (Bruker Daltonics, Leipzig, Germany) equipped with an Nd:YAG laser. The 119 
laser power was optimized to minimize in-source decay of phosphate of nucleotides. Data 120 
were acquired in the reflectron mode with raster scanning using a pitch distance of 100 121 
µm. Each mass spectrum was the result of 300 laser shots at each data point. Signals 122 
between m/z 50 and 1000 were collected. Molecular identification was performed based 123 
on previous reports (Sugiura et al., 2014; Sugiura, Taguchi, & Setou, 2011). 124 
Image reconstruction was performed using FlexImaging 4.0 software (Bruker Daltonics, 125 
Leipzig, Germany). 126 
Histology 127 
After measurements, animals were deeply anesthetized and transcardially 128 
perfused with PB containing 4% PFA. Immunohistochemistry of EYFP to confirm 129 
neuronal or astrocytic expression of ChR2(C128S)-EYFP was performed using 130 
affinity-purified antibodies against heat-denatured GFP (a gift from Dr. Kouichi C. 131 
Nakamura) (Nakamura, Kameda, Koshimizu, Yanagawa, & Kaneko, 2008). In 132 
situ hybridization to examine c-fos mRNA expression was performed as reported 133 
previously (Takata et al., 2015). 134 
Data processing and analysis 135 
Analysis of fMRI data was performed using SPM12 software 136 
(www.fil.ion.ucl.ac.uk/spm) as previously (Takata et al., 2015; Yoshida et al., 137 
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2016). This consisted of head movement correction, adjustments of acquisition timing 138 
across slices, and smoothing using a Gaussian kernel of 0.4-mm full width at half 139 
maximum. Structural and functional images were spatially normalized to a standard 140 
structural brain averaged from 20 C57BL/6 mice. Statistical t-maps were calculated using 141 
a generalized linear model (GLM) with random effects using a block design regarding the 142 
optogenetic activation, delayed vascular response and head movement. Activation was 143 
detected using a statistical threshold of uncorrected P < 0.005 and a cluster size > 10, 144 
which were objectively chosen via Monte Carlo simulations using the “AlphaSim” 145 
implementation in a toolbox REST (Song et al., 2011), resulting in a family-wise error 146 
rate of P < 0.05. The parameters used for the simulations were as follows: full width at 147 
half maximum, 0.4 mm; cluster connection radius, 0.2 mm; individual voxel threshold 148 
probability, 0.005; number of Monte Carlo iterations, 100,000; voxels in mask, 13441. 149 
Timecourses of BOLD signals were obtained with a spherical ROI of 0.7-mm diameter, 150 
using the SPM toolbox MarsBar (http://marsbar.sourceforge.net). 151 
Electrophysiological data analysis was performed using MATLAB (R2014a, 152 
MathWorks, MA, USA). LFPs were decomposed to frequency bands of delta (1–4 Hz), 153 
theta (6–9 Hz), gamma (40–90 Hz), and high frequency oscillation (HFO; 140–200 Hz) 154 
(Buzsáki et al., 2003). Power values of LFP were logged and z-scored by each 155 
frequency band with its mean and standard deviation (SD) during the period before the 156 
first blue illumination for each recording session (Carr, Karlsson, & Frank, 2012). 157 
MUA was extracted by thresholding the high-pass filtered LFP (> 300 Hz) with 4σ where 158 
σ = median{absolute value of the filtered LFP / 0.6745} (Quiroga, Nadasdy, & 159 
Ben-Shaul, 2004). Count of MUA was binned to 1.5 s. Data are expressed as mean ± 160 
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SEM across animals, except where otherwise noted. Two-tailed t-tests were used for 161 
comparisons of two population means, unless otherwise noted. 162 
 163 
Supplementary Results 164 
Optogenetic stimulation of astrocytes as well as 165 
neurons evokes BOLD signal response. 166 
Subcortical BOLD signal in Astrocyte-ChR2 mice may reflect 167 
direct photo-activation of astrocytes 168 
Other than the cortex, a BOLD signal response was observed in the hippocampus 169 
and thalamus of Neuron- and Astrocyte-ChR2 mice, respectively (Fig. 2a, c). Subcortical 170 
BOLD signal in Astrocyte-ChR2 mice may reflect direct photo-activation of astrocytes 171 
due to an especially high expression level of ChR2(C128S) (Fig. 1d), and higher 172 
sensitivity of ChR2(C128S), which is ~1000 times more sensitive than conventional 173 
ChR2 (Mattis et al., 2012). To confirm this scenario, we generated a triple transgenic 174 
mice (Astrocyte-ChR2 mice with Emx1-Cre) that express ChR2(C128S) in astrocytes of 175 
ventral but not dorsal part of the brain (Supplementary Fig. 2a, b). Transcranial 176 
illumination of Astrocyte-ChR2 mice with Emx1-Cre evoked BOLD signal response in 177 
subcortical region, indicating that sufficient amount of light reached the subcortical 178 
region to activate ChR2(C128S) (Supplementary Fig. 2c, d). 179 
Light illumination for optogenetic stimulation seemed not 180 
enough to evoke BOLD signal response through visual 181 
stimulation nor brain-tissue heating 182 
Illumination using only yellow light, which does not open ChR2(C128S), did not 183 
evoke BOLD signal fluctuations in neither Neuron- nor Astrocyte-ChR2 mice 184 
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(Supplementary Fig. 3a, b). This suggests that the BOLD signal response was not derived 185 
from activation of the visual pathways of mice (Schmid et al., 2016); nor was it an 186 
artefact of the illumination heating the brain tissue (Christie et al., 2012). It is recently 187 
shown that blue light triggers arteriole dilations, independently of heat (Rungta, 188 
Osmanski, Boido, Tanter, & Charpak, 2017). Amount of light used in our study (0.15 mW 189 
for 0.5 or 5 s; see Supplementary Materials and Methods) is below the lower limit of the 190 
effect (0.5~1 mW for 2 s with 40% duty cycle). Also note that the reported blood flow 191 
increases by blue light per se returned to baseline shortly, while our BOLD signal 192 
response lasted more than 30 s after blue light illumination because ChR2(C128S) is a 193 
step-function opsin. Moreover, we reported previously that blue light illumination with 194 
higher power (1~2 mW for 0.5 s) did not evoke BOLD signal fluctuation in wild type 195 
mice (Takata et al., 2015). 196 
Behavioral state change seemed not to contaminate BOLD 197 
signal fluctuation upon optogenetic activation of astrocytes 198 
or neurons 199 
It's reported that change in behavioral state of mice (i.e. locomotion and startle 200 
response) may cause widespread astrocyte excitation in the brain (Nimmerjahn, Mukamel, 201 
& Schnitzer, 2009; Paukert et al., 2014; Srinivasan et al., 2015). If optogenetic 202 
stimulation results in behavioral response, it's possible that BOLD signal fluctuation in 203 
our study may reflect behavioral state-change that results in astrocyte excitation, rather 204 
than optogenetic astrocyte activation. To address this possibility, we performed 205 
open-field tests using Neuron-ChR2 or Astrocyte-ChR2 mice. Light illumination did not 206 
evoke overt motor responses in our experimental condition (Supplementary Fig. 4). 207 
Moreover, we performed ofMRI using anesthetized Astrocyte-ChR2 mice, demonstrating 208 
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BOLD signal response upon optogenetic astrocyte activation (Supplementary Fig. 2e, f). 209 
These results imply that behavioral state-change was not a dominant cause for the BOLD 210 
signal response in the present study. That being said, contribution of behavioral 211 
state-change in BOLD signal fluctuation cannot be ruled out completely in the current 212 
study. Future investigation that realizes simultaneous Ca
2+
 imaging and optogenetic 213 
manipulation of neurons and/or astrocytes in vivo should deepen our understandings of 214 
the role of astrocytes on BOLD signal induction. In performing this experiment, 215 
sophisticated experimental setup would be necessary to avoid possible interference of 216 
excitation light for Ca
2+
 imaging on photocycle of ChR2(C128S). 217 
 218 
Supplementary Discussion 219 
AC is involved in many physiological effects, such as increased glucose metabolism (Ori, 220 
Freo, Pizzolato, & Dam, 2002), acetylcholine release (Imperato, Ramacci, & 221 
Angelucci, 1989), and cerebral blood flow in the brain (Postiglione et al., 1991). It is 222 
tempting to speculate that astrocyte-derived AC can be an energy substrate for neurons by 223 
fueling tricarboxylic acid (TCA) cycle in neurons because 1) acyl-carnitine including AC 224 
is known to facilitate influx and efflux of acetyl groups across the inner membrane of 225 
mitochondria, and 2) AC can be converted to neurotransmitters such as glutamate and 226 
GABA via TCA-cycle (Hadera et al., 2016; Jones, McDonald, & Borum, 2010; 227 
Scafidi et al., 2010). Additionally, it’s noteworthy that co-occurrence of 228 
carnitine-decrease and AC-increase at the site of optogenetic astrocyte activation 229 
indicates de novo synthesis of AC in the brain upon astrocyte activation. AC has been 230 
considered to enter the brain through the blood-brain barrier via the high affinity, Na
+
 231 
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dependent organic cation/carnitine transporters such as OCTN2, which is abundant on 232 
astrocyte endfeet (Scafidi et al., 2010).  233 
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Supplementary Figure Legends 344 
Supplementary Figure 1. Engineering of neuron-, 345 
astrocyte-, or ventral astrocyte-specific ChR2(C128S) 346 
mice. 347 
(a) Gene manipulation strategies. Top, tetO cassette was inserted downstream of the Actb 348 
polyA signal in tetO knockin mice, but with no gene induction. Middle, tTA-mediated 349 
gene induction. tTA binds to the tTA-dependent promoter (tetO) and transactivates the 350 
transcription of ChR2(C128S) in double-transgenic mice. Bottom, The tetO cassette was 351 
removed by crossing with Cre mice, yielding Cre recombination. tetO, Tetracycline 352 
operator; tTA, tetracycline-controlled transcriptional activator; pA, polyadenylation 353 
signal; loxP, locus of X-over P1. 354 
(b) Strategy for the generation of neuron-, astrocyte-, or ventral astrocyte-specific 355 
ChR2(C128S) mice. Neuron-ChR2 mice: Chrm4-tTA induced the expression of ChR2 in 356 
neurons, resulting in Chrm4-tTA::tetO-ChR2(C128S)-EYFP double-transgenic mice. 357 
Astrocyte-ChR2 mice: Mlc1-tTA induced the expression of ChR2 in astrocytes, resulting 358 
in Mlc1-tTA::tetO-ChR2(C128S)-EYFP double-transgenic mice. Astrocyte-ChR2 mice 359 
with Emx1-Cre: Mlc1-tTA induced the expression of ChR2 in astrocytes in ventral 360 
telencephalon (lower panel), but not in dorsal telencephalon by Cre-mediated removal of 361 
tetO cassette (upper panel). This results in Emx1-Cre; 362 
Mlc1-tTA::tetO-ChR2(C128S)-EYFP triple transgenic mice. 363 
Supplementary Figure 2. Transcranial light illumination 364 
evoked BOLD signal response in the subcortical region 365 
of Astrocyte-ChR2 with Emx1-Cre. 366 
(a) Left, Schematic expression pattern of Emx1-Cre (black area) in a coronal brain 367 
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section of Emx1-Cre mouse (Tanaka et al., 2007). Right, DAB immunohistochemistry 368 
against YFP (ChR2-marker) on coronal sections of the brain from Astrocyte-ChR2 with 369 
Emx1-Cre mice. This demonstrates a lack of ChR2(C128S) expression in the dorsal 370 
telencephalon. Scale bar: 1 mm. (b) A strategic diagram to generate Emx1-Cre; 371 
Mlc1-tTA::tetO-ChR2(C128S)-EYFP triple transgenic mice. (c) Transcranial light 372 
illumination of the brain from n = 2 Astrocyte-ChR2 with Emx1-Cre mice resulted in 373 
BOLD response at subcortical region (an arrow points at superior colliculus). This 374 
demonstrates that sufficient light reached through the skull to the subcortical region to 375 
activate the ultra-sensitive ChR2(C128S) (Mattis et al., 2012). (d) Time-course of 376 
BOLD signal fluctuation upon optogenetic activation of astrocytes at an arrow in (c). 377 
Blue and yellow vertical lines show timing of illumination for each color. (e, f) ofMRI 378 
using anesthetized Astrocyte-ChR2 mice (three measurements from 2 mice) 379 
demonstrated BOLD signal fluctuation upon optogenetic activation of astrocytes 380 
without behavioral response of mice. The duration of blue and yellow light was 0.5 s 381 
only in this observation. Medetomidine was used for anesthesia (Takata et al., 2015). 382 
Supplementary Figure 3. BOLD signal fluctuation upon 383 
optogenetic stimulation of neurons or astrocytes with 384 
only yellow light or reduced power light. 385 
(a, b) Time course of BOLD signal fluctuations in the cortex of n = 7 Neuron- (a) or n = 8 386 
Astrocyte-ChR2 mice (b), upon illumination by pairs of yellow lights separated by 30 s. 387 
(c, d) Time courses of BOLD signal responses in the cortex of n = 13 Neuron- (c) or n = 388 
11 Astrocyte-ChR2 mice (d), upon optogenetic activation using light power modulated to 389 
10%, 20%, and 100% of that used in other experiments (i.e. Figs. 2–4). Grey shading 390 
indicates the SEM. 391 
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Supplementary Figure 4. Optogenetic stimulation of 392 
either neurons or astrocytes did not induce behavioral 393 
response. 394 
(a) A photo of a freely moving mouse with an optical fiber attached on the surface of its 395 
skull. (b) Representative data of the tracking of the mouse position during a habituation 396 
period (8.5 min; Habituation) and a following period after habituation with light 397 
illumination (8.5 min; Light). Scale bar: 5 cm. (c) Representative locomotion velocity 398 
(black trace, left axis) and travel distance (gray trace, right axis) of a Neuron-ChR2 399 
(left) or Astrocyte-ChR2 (right) mouse are plotted against time (bin width = 1 s). (d) 400 
Grouped data that compares mean velocity of 3 Neuron-ChR2 (left panel) or 3 401 
Astrocyte-ChR2 (right panel) mice during the last 30 s of a habituation period, 30 s 402 
prior to the blue light illumination (Pre), and 30 s after the blue light illumination 403 
(Light). Mean velocity of mice was not modulated by light illumination (1.9 ± 0.1 404 
versus 3.2 ± 1.4, P = 0.11 for Neuron-ChR2 mice, 1.2 ± 0.2 versus 1.3 ± 0.3, P = 0.61 405 
for Astrocyte-ChR2 mice; paired t-test). Data are mean ± SD. NS: not significant. 406 
Supplementary Figure 5. Electrophysiological response 407 
upon optogenetic stimulation of neurons or astrocytes 408 
with only yellow light or reduced power light. 409 
(a, b) Time courses of LFP-power at each frequency band from n = 5 Neuron- (a) or n = 5 410 
Astrocyte-ChR2 mice (b), upon illumination by pairs of yellow lights. Data are 411 
normalized (see methods). Vertical yellow lines indicate the delivery of yellow light 412 
pulses. (c, d) Relative number of MUA counts per 1.5-s bin, recorded at the most 413 
superficial 10 channels of the silicon probe electrode in the cortex of n = 5 Neuron-ChR2 414 
(c) or n = 5 Astrocyte-ChR2 mice (d). (e, f) Time courses of LFP-power at each frequency 415 
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band from n = 6 Neuron- (e) or n = 5 Astrocyte-ChR2 mice (f), upon illumination by blue 416 
and yellow light, whose power was modulated as described in Supplementary Fig. 1. Data 417 
are normalized (see methods). Vertical blue and yellow lines indicate the delivery of light 418 
pulses of each color. (g, h) Relative number of MUA counts per 1.5-s bin, recorded at the 419 
most superficial 10 channels of the silicon probe electrode in the cortex of n = 6 Neuron- 420 
(g) or n = 5 Astrocyte-ChR2 mice (h). Gray shading indicates SEM which envelopes a 421 
mean trace. 422 
Supplementary Figure 6. Representative images of 423 
other metabolites after optogenetic stimulation of 424 
astrocytes. 425 
(a) Additional representative IMS images for AC/carnitine ratio (lower left) and 426 
13
C2-AC/carnitine ratio (lower right) after optogenetic stimulation of the left cortex of an 427 
Astrocyte-ChR2 mouse. Upper images are optical images of a coronal brain section used 428 
for IMS. (b) Representative IMS images for glucose flux (left column), NADH (top panel 429 
at right column), and adenosine-nucleotides (bottom three panels at right column) after 430 
optogenetic stimulation of the cortex of the same Astrocyte-ChR2 mouse as Fig. 4d. 431 
Images (top to bottom, left to right) represent lactate, 
13
C2-lactate, glutamate, 432 
13
C2-glutamate, NADH, ATP, ADP, and AMP. Arrow heads in the panels indicate regions 433 
that showed significant increase of AC (Fig. 4d). Scale bar, 2 mm. 434 
Supplementary Figure 7. AC-increase upon optogenetic 435 
stimulation of astrocytes demonstrated by CE/ESI/MS 436 
technique. 437 
Amount of carnitine, AC, and 
13
C2-AC in the dorsal cortexes that were ipsilateral and 438 
contralateral to the optical stimulation was compared (upper panel), using a CE/ESI/MS 439 
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technique that analyzed micro-dissected brain tissues from n = 3 Astrocyte-ChR2 mice. 440 
Amount of AC in the ipsilateral cortex was significantly higher than that in the 441 
contralateral cortex after optogenetic stimulation (*P = 0.04, paired t-test; lower middle). 442 
There was tendency of carnitine decrease (lower left) and 
13
C2-AC increase (lower 443 
right) in the ipsilateral cortex (P = 0.54 for carnitine and P = 0.23 for 
13
C2-AC, paired 444 
t-test). These results support the imaging observation by IMS (Fig. 4d).  445 
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